These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 16484922

  • 1. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S, Di Paola R, Mazzon E, Patel NS, Genovese T, Muià C, Crisafulli C, Caputi AP, Thiemermann C.
    Crit Care Med; 2006 Apr; 34(4):1168-77. PubMed ID: 16484922
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Fulia F, Cuzzocrea E, Di Rosa M, Caputi AP, Thiemermann C.
    Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
    [Abstract] [Full Text] [Related]

  • 3. Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice.
    Di Paola R, Mazzon E, Genovese T, Crisafulli C, Bramanti P, Caminiti R, Esposito E, Fink MP, Cuzzocrea S.
    Crit Care Med; 2009 Jan; 37(1):270-82. PubMed ID: 19050619
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock.
    Cuzzocrea S, Mazzon E, Di Paola R, Genovese T, Serraino I, Dugo L, Cuzzocrea E, Fulia F, Caputi AP, Salvemini D.
    Crit Care Med; 2004 Jan; 32(1):157-67. PubMed ID: 14707575
    [Abstract] [Full Text] [Related]

  • 5. Green tea polyphenol extract attenuates zymosan-induced non-septic shock in mice.
    Di Paola R, Mazzon E, Muià C, Crisafulli C, Genovese T, Di Bella P, Esposito E, Menegazzi M, Meli R, Suzuki H, Cuzzocrea S.
    Shock; 2006 Oct; 26(4):402-9. PubMed ID: 16980889
    [Abstract] [Full Text] [Related]

  • 6. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
    Mondello S, Galuppo M, Mazzon E, Italiano D, Mondello P, Aloisi C, Cuzzocrea S.
    Eur J Pharmacol; 2011 May 01; 658(1):28-40. PubMed ID: 21349270
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Caminiti R, Esposito E, Di Bella P, Cuzzocrea S.
    Shock; 2008 May 01; 29(5):560-71. PubMed ID: 17724436
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.
    Genovese T, Di Paola R, Catalano P, Li JH, Xu W, Massuda E, Caputi AP, Zhang J, Cuzzocrea S.
    Crit Care Med; 2004 Jun 01; 32(6):1365-74. PubMed ID: 15187521
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
    Di Paola R, Galuppo M, Mazzon E, Paterniti I, Bramanti P, Cuzzocrea S.
    Pharmacol Res; 2010 Feb 01; 61(2):175-87. PubMed ID: 19819333
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity.
    Di Paola R, Mazzon E, Muià C, Crisafulli C, Genovese T, Di Bella P, Esposito E, Menegazzi M, Meli R, Suzuki H, Cuzzocrea S.
    Nitric Oxide; 2007 Feb 01; 16(1):118-30. PubMed ID: 16889996
    [Abstract] [Full Text] [Related]

  • 19. Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.
    Cuzzocrea S, Chatterjee PK, Mazzon E, Serraino I, Dugo L, Centorrino T, Barbera A, Ciccolo A, Fulia F, McDonald MC, Caputi AP, Thiemermann C.
    Crit Care Med; 2002 Oct 01; 30(10):2284-94. PubMed ID: 12394957
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin reduces the development of experimental inflammatory bowel disease.
    Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muià C, De Sarro A, Thiemermann C.
    J Pharmacol Exp Ther; 2004 Dec 01; 311(3):1272-80. PubMed ID: 15302898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.